We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.53B
AUM Growth
+$224M
Cap. Flow
+$172M
Cap. Flow %
11.23%
Top 10 Hldgs %
40.36%
Holding
96
New
31
Increased
23
Reduced
14
Closed
23

Top Buys

Rank Stock Value
1
EPC icon
Edgewell Personal Care
EPC
+$50.2M
2
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$38.2M
3
SJM icon
J.M. Smucker
SJM
+$36.4M
4
INCY icon
Incyte
INCY
+$29.3M
5
TBPH icon
Theravance Biopharma
TBPH
+$28M

Top Sells

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$51.6M
2
UTHR icon
United Therapeutics
UTHR
+$43.6M
3
CAKE icon
Cheesecake Factory
CAKE
+$37.1M
4
POST icon
Post Holdings
POST
+$29.7M
5
ASRT
Assertio
ASRT
+$28.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.79%
2 Consumer Discretionary 23.39%
3 Consumer Staples 8.62%
4 Communication Services 0.74%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YELP icon
51
Yelp
YELP
$1.51B
$7.84M 0.51%
+200,000
New +$8.65M
CRSP icon
52
CRISPR Therapeutics
CRSP
$4.68B
$7.29M 0.48%
+124,000
New +$7.06M
DBI icon
53
Designer Brands
DBI
$322M
$7.23M 0.47%
+280,000
New +$6.69M
NVLN
54
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$6.83M 0.45%
1,856,000
– –
ALIM
55
DELISTED
Alimera Sciences
ALIM
$6.79M 0.44%
462,400
– –
SLDB icon
56
Solid Biosciences
SLDB
$785M
$6.41M 0.42%
+12,000
New +$3.69M
CMRX
57
DELISTED
Chimerix, Inc.
CMRX
$5.99M 0.39%
1,258,000
+226,800
+22% +$1.08M
ZOES
58
DELISTED
Zoe's Kitchen, Inc.
ZOES
$5.79M 0.38%
+593,321
New +$7.53M
CPRX
59
DELISTED
Catalyst Pharmaceutical
CPRX
$5.3M 0.35%
+1,700,000
New +$5.16M
FRTX
60
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$5.01M 0.33%
13,843
+6,541
+90% +$3.08M
IPCI
61
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$3.84M 0.25%
860,000
– –
META icon
62
Meta Platforms (Facebook)
META
$1.51T
$3.5M 0.23%
+18,000
New +$3.25M
AMZN icon
63
Amazon
AMZN
$2.48T
$3.4M 0.22%
40,000
-60,000
-60% -$4.76M
STDY
64
DELISTED
SteadyMed Ltd
STDY
$2.24M 0.15%
+497,044
New +$2.03M
ATXS
65
DELISTED
Astria Therapeutics
ATXS
$1.92M 0.13%
+33,333
New +$3.07M
DYNT
66
DELISTED
Dynatronics Corp
DYNT
$1.56M 0.1%
108,283
+1,899
+2% +$28K
NOVN
67
DELISTED
Novan, Inc. Common Stock
NOVN
$1.47M 0.1%
50,000
-50,000
-50% -$1.51M
TRAW icon
68
Traws Pharma
TRAW
$7.81M
$683K 0.04%
300
+60
+25% +$174K
BDSI
69
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$357K 0.02%
120,889
-679,111
-85% -$1.61M
VXRT
70
DELISTED
Vaxart
VXRT
$235K 0.02%
+77,599
New +$358K
ACHV icon
71
Achieve Life Sciences
ACHV
$634M
$234K 0.02%
+3,100
New +$632K
AIXC
72
AIxCrypto Holdings Inc
AIXC
$16.7M
$36K ﹤0.01%
1
-14
-93% -$518K
ASMB icon
73
Assembly Biosciences
ASMB
$507M
– –
-10,667
Closed -$6.29M
ATNM icon
74
Actinium Pharmaceuticals
ATNM
$27.2M
– –
-203,333
Closed -$2.23M
AVDL
75
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-1,836,000
Closed -$13.4M
1 2
3
4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Armistice Capital held 96 positions worth $1.53B, up 17% from $1.31B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Armistice Capital deployed $172M of net new capital in Q2 2018, opening 31 new positions and adding to 23 existing holdings. Its largest new stake was Edgewell Personal Care: 1,092,000 shares worth $55.1M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Assertio, an estimated $28.4M trimmed.

  • Armistice Capital's largest Q2 2018 buy was Edgewell Personal Care: 1,092,000 shares worth $55.1M.
  • Armistice Capital added most to Despegar.com in Q2 2018, an estimated $25.3M increase.
  • Armistice Capital's biggest Q2 2018 reduction was Assertio, cutting an estimated $28.4M.
  • Armistice Capital fully exited Freshpet in Q2 2018, selling an estimated $51.6M.
  • Armistice Capital's ten largest holdings make up 40% of its $1.53B portfolio in Q2 2018.
  • Armistice Capital opened 31 new positions and closed 23 in Q2 2018.
  • Armistice Capital's portfolio value rose 17% quarter-over-quarter to $1.53B.

Based on Armistice Capital's 13F filing for Q2 2018, filed 14 Aug 2018.